Incyte Corp (INCY): R&D Expense
$2.05B
Year ended 2025-12-31
$2.13B
Trailing 12 months to 2026-03-31
+8.9%
3-year compound annual growth
-1.5%
5-year compound annual growth
+15.6%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.05B | -21.4% | 2026-02-10, From 2025-01-01 |
| 2024-12-31 | $2.61B | +60.2% | 2026-02-10, From 2024-01-01 |
| 2023-12-31 | $1.63B | +2.6% | 2026-02-10, From 2023-01-01 |
| 2022-12-31 | $1.59B | +8.8% | 2025-02-10, From 2022-01-01 |
| 2021-12-31 | $1.46B | -34.2% | 2024-02-13, From 2021-01-01 |
| 2020-12-31 | $2.22B | +92.0% | 2023-02-07, From 2020-01-01 |
| 2019-12-31 | $1.15B | -3.7% | 2022-02-08, From 2019-01-01 |
| 2018-12-31 | $1.20B | -9.7% | 2021-02-09, From 2018-01-01 |
| 2017-12-31 | $1.33B | +127.9% | 2020-02-13, From 2017-01-01 |
| 2016-12-31 | $581.86M | +21.3% | 2019-02-14, From 2016-01-01 |
| 2015-12-31 | $479.51M | +38.0% | 2018-02-15, From 2015-01-01 |
| 2014-12-31 | $347.52M | +33.4% | 2017-02-14, From 2014-01-01 |
| 2013-12-31 | $260.44M | +23.8% | 2016-02-12, From 2013-01-01 |
| 2012-12-31 | $210.39M | +17.7% | 2015-02-17, From 2012-01-01 |
| 2011-12-31 | $178.71M | +44.3% | 2014-02-21, From 2011-01-01 |
| 2010-12-31 | $123.88M | +3.7% | 2013-02-21, From 2010-01-01 |
| 2009-12-31 | $119.44M | n/a | 2012-02-22, From 2009-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Incyte Corp (INCY) | 2025-12-31 | $2.05B | -21.4% |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | $20.82M | -6.3% |
| OmniAb, Inc. (OABI) | 2025-12-31 | $47.75M | -13.3% |
| Foxo Technologies Inc. (FOXO) | 2025-12-31 | $182.5K | -41.6% |
| bioAffinity Technologies, Inc. (BIAF) | 2025-12-31 | $1.38M | -5.3% |
| Absci Corp (ABSI) | 2025-12-31 | $81.42M | +27.5% |
| iSpecimen Inc. (ISPC) | 2024-12-31 | $1.49M | -7.8% |
| OneMedNet Corp (ONMD) | 2025-12-31 | $1.51M | +3.3% |
Compare INCY, MXCT, OABI, FOXO side by side · Screen every company in Services-Commercial Physical & Biological Research ↗